Discontinued — last reported Q3 '23
Natera, Inc. Sequencing Services — Equipment And Services Received increased by 40.0% to $1.40M in Q3 2023 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests active expansion of testing capacity or technological upgrades, whereas a decrease may signal a slowdown in capital investment or a shift toward asset-light operational models.
This metric tracks the value of equipment and specialized services acquired or received by the Sequencing Services segme...
Similar to capital expenditure disclosures in other biotech firms, this metric highlights the physical and service-based resources fueling diagnostic revenue growth.
ntra_segment_sequencing_services_equipment_and_services_received| Q2 '23 | Q3 '23 | |
|---|---|---|
| Value | $1.00M | $1.40M |
| QoQ Change | — | +40.0% |